Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
    EC 2.1
    EC 2.2
    EC 2.3
    EC 2.4
    EC 2.5
    EC 2.6
    EC 2.7
      EC 2.7.1
        EC 2.7.1.1
        EC 2.7.1.2
        EC 2.7.1.3
        EC 2.7.1.4
        EC 2.7.1.5
        EC 2.7.1.6
        EC 2.7.1.7
        EC 2.7.1.8
        EC 2.7.1.9
        EC 2.7.1.10
        EC 2.7.1.11
        EC 2.7.1.12
        EC 2.7.1.13
        EC 2.7.1.14
        EC 2.7.1.15
        EC 2.7.1.16
        EC 2.7.1.17
        EC 2.7.1.18
        EC 2.7.1.19
        EC 2.7.1.20
        EC 2.7.1.21
        EC 2.7.1.22
        EC 2.7.1.23
        EC 2.7.1.24
        EC 2.7.1.25
        EC 2.7.1.26
        EC 2.7.1.27
        EC 2.7.1.28
        EC 2.7.1.29
        EC 2.7.1.30
        EC 2.7.1.31
        EC 2.7.1.32
        EC 2.7.1.33
        EC 2.7.1.34
        EC 2.7.1.35
        EC 2.7.1.36
        EC 2.7.1.37
        EC 2.7.1.38
        EC 2.7.1.39
        EC 2.7.1.40
        EC 2.7.1.41
        EC 2.7.1.42
        EC 2.7.1.43
        EC 2.7.1.44
        EC 2.7.1.45
        EC 2.7.1.46
        EC 2.7.1.47
        EC 2.7.1.48
        EC 2.7.1.49
        EC 2.7.1.50
        EC 2.7.1.51
        EC 2.7.1.52
        EC 2.7.1.53
        EC 2.7.1.54
        EC 2.7.1.55
        EC 2.7.1.56
        EC 2.7.1.57
        EC 2.7.1.58
        EC 2.7.1.59
        EC 2.7.1.60
        EC 2.7.1.61
        EC 2.7.1.62
        EC 2.7.1.63
        EC 2.7.1.64
        EC 2.7.1.65
        EC 2.7.1.66
        EC 2.7.1.67
        EC 2.7.1.68
        EC 2.7.1.69
        EC 2.7.1.70
        EC 2.7.1.71
        EC 2.7.1.72
        EC 2.7.1.73
        EC 2.7.1.74
        EC 2.7.1.75
        EC 2.7.1.76
        EC 2.7.1.77
        EC 2.7.1.78
        EC 2.7.1.79
        EC 2.7.1.80
        EC 2.7.1.81
        EC 2.7.1.82
        EC 2.7.1.83
        EC 2.7.1.84
        EC 2.7.1.85
        EC 2.7.1.86
        EC 2.7.1.87
        EC 2.7.1.88
        EC 2.7.1.89
        EC 2.7.1.90
        EC 2.7.1.91
        EC 2.7.1.92
        EC 2.7.1.93
        EC 2.7.1.94
        EC 2.7.1.95
        EC 2.7.1.96
        EC 2.7.1.97
        EC 2.7.1.98
        EC 2.7.1.99
        EC 2.7.1.100
        EC 2.7.1.101
        EC 2.7.1.102
        EC 2.7.1.103
        EC 2.7.1.104
        EC 2.7.1.105
        EC 2.7.1.106
        EC 2.7.1.107
        EC 2.7.1.108
        EC 2.7.1.109
        EC 2.7.1.110
        EC 2.7.1.111
        EC 2.7.1.112
        EC 2.7.1.113
        EC 2.7.1.114
        EC 2.7.1.115
        EC 2.7.1.116
        EC 2.7.1.117
        EC 2.7.1.118
        EC 2.7.1.119
        EC 2.7.1.120
        EC 2.7.1.121
        EC 2.7.1.122
        EC 2.7.1.123
        EC 2.7.1.124
        EC 2.7.1.125
        EC 2.7.1.126
        EC 2.7.1.127
        EC 2.7.1.128
        EC 2.7.1.129
        EC 2.7.1.130
        EC 2.7.1.131
        EC 2.7.1.132
        EC 2.7.1.133
        EC 2.7.1.134
        EC 2.7.1.135
        EC 2.7.1.136
        EC 2.7.1.137
        EC 2.7.1.138
        EC 2.7.1.139
        EC 2.7.1.140
        EC 2.7.1.141
        EC 2.7.1.142
        EC 2.7.1.143
        EC 2.7.1.144
        EC 2.7.1.145
        EC 2.7.1.146
        EC 2.7.1.147
        EC 2.7.1.148
        EC 2.7.1.149
        EC 2.7.1.150
        EC 2.7.1.151
        EC 2.7.1.152
        EC 2.7.1.153
        EC 2.7.1.154
        EC 2.7.1.155
        EC 2.7.1.156
        EC 2.7.1.157
        EC 2.7.1.158
        EC 2.7.1.159
        EC 2.7.1.160
        EC 2.7.1.161
        EC 2.7.1.162
      EC 2.7.2
      EC 2.7.3
      EC 2.7.4
      EC 2.7.5
      EC 2.7.6
      EC 2.7.7
      EC 2.7.8
      EC 2.7.9
      EC 2.7.10
      EC 2.7.11
      EC 2.7.12
      EC 2.7.13
      EC 2.7.14
    EC 2.8
    EC 2.9
  EC 3: Hydrolases
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 2.7.1.37 - obsolete, now divided into EC 2.7.11.1, EC 2.7.11.8, EC 2.7.11.9, EC 2.7.11.10, EC 2.7.11.11, EC 2.7.11.12, EC 2.7.11.13, EC 2.7.11.21, EC 2.7.11.22, EC 2.7.11.24, EC 2.7.11.25, EC 2.7.11.30 and EC 2.7.12.1



3D structures of EC 2.7.1.37 in Protein Data Bank

updated: 22 January 2021, 10:45

In total: 413 PDB structures of EC 2.7.1.37:
  1. 1apm: 2.0 Angstrom Refined Crystal Structure of The Catalytic Subunit of Camp-dependent Protein Kinase Complexed with a Peptide Inhibitor and Detergent
  2. 1aq1: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor Staurosporine
  3. 1atp: 2.2 Angstrom Refined Crystal Structure of The Catalytic Subunit of Camp-dependent Protein Kinase Complexed with Mnatp and a Peptide Inhibitor
  4. 1b38: Human Cyclin-dependent Kinase 2
  5. 1b39: Human Cyclin-dependent Kinase 2 Phosphorylated on Thr 160
  6. 1b6c: Crystal Structure of The Cytoplasmic Domain of The Type I Tgf-beta Receptor in Complex with Fkbp12
  7. 1bdy: C2 Domain from Protein Kinase C Delta
  8. 1bkx: A Binary Complex of The Catalytic Subunit of Camp-dependent Protein Kinase and Adenosine Further Defines Conformational Flexibility
  9. 1bx6: Crystal Structure of The Potent Natural Product Inhibitor Balanol in Complex with The Catalytic Subunit of Camp- Dependent Protein Kinase
  10. 1ckp: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor Purvalanol B
  11. 1ctp: Structure of The Mammalian Catalytic Subunit of Camp- Dependent Protein Kinase and an Inhibitor Peptide Displays an Open Conformation
  12. 1daw: Crystal Structure of a Binary Complex of Protein Kinase Ck2 (alpha-subunit) and Mg-amppnp
  13. 1day: Crystal Structure of a Binary Complex of Protein Kinase Ck2 (alpha-subunit) and Mg-gmppnp
  14. 1ddm: Solution Structure of The Numb Ptb Domain Complexed to a Nak Peptide
  15. 1ds5: Dimeric Crystal Structure of The Alpha Subunit in Complex with Two Beta Peptides Mimicking The Architecture of The Tetrameric Protein Kinase Ck2 Holoenzyme.
  16. 1e1v: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor Nu2058
  17. 1e1x: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor Nu6027
  18. 1e9h: Thr 160 Phosphorylated Cdk2 - Human Cyclin A3 Complex with The Inhibitor Indirubin-5-sulphonate Bound
  19. 1f0q: Crystal Structure of The Alpha Subunit of Protein Kinase Ck2 in Complex with The Nucleotide Competitive Inhibitor Emodin
  20. 1fmo: Crystal Structure of a Polyhistidine-tagged Recombinant Catalytic Subunit of Camp-dependent Protein Kinase Complexed with The Peptide Inhibitor Pki(5-24) and Adenosine
  21. 1fot: Structure of The Unliganded Camp-dependent Protein Kinase Catalytic Subunit from Saccharomyces Cerevisiae
  22. 1fvt: The Structure of Cyclin-dependent Kinase 2 (cdk2) in Complex with an Oxindole Inhibitor
  23. 1fvv: The Structure of Cdk2/cyclin a in Complex with an Oxindole Inhibitor
  24. 1g3n: Structure of a P18(INK4C)-CDK6-K-CYCLIN Ternary Complex
  25. 1gih: Human Cyclin Dependent Kinase 2 Complexed with The Cdk4 Inhibitor
  26. 1gii: Human Cyclin Dependent Kinase 2 Complexed with The Cdk4 Inhibitor
  27. 1gij: Human Cyclin Dependent Kinase 2 Complexed with The Cdk4 Inhibitor
  28. 1gng: Glycogen Synthase Kinase-3 Beta (gsk3) Complex with Frattide Peptide
  29. 1gz8: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor 2-amino-6-(3'-methyl-2'-oxo)butoxypurine
  30. 1h00: Cdk2 in Complex with a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor
  31. 1h07: Cdk2 in Complex with a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor
  32. 1h08: Cdk2 in Complex with a Disubstituted 2, 4-bis Anilino Pyrimidine Cdk4 Inhibitor
  33. 1h0v: Human Cyclin Dependent Protein Kinase 2 in Complex with The Inhibitor 2-amino-6-[(r)-pyrrolidino-5'-yl]methoxypurine
  34. 1h0w: Human Cyclin Dependent Protein Kinase 2 in Complex with The Inhibitor 2-amino-6-[cyclohex-3-enyl]methoxypurine
  35. 1h8f: Glycogen Synthase Kinase 3 Beta.
  36. 1hck: Human Cyclin-dependent Kinase 2
  37. 1hcl: Human Cyclin-dependent Kinase 2
  38. 1i09: Structure of Glycogen Synthase Kinase-3 (GSK3B)
  39. 1ia9: Crystal Structure of The Atypical Protein Kinase Domain of a Trp Ca-channel, Chak (amppnp Complex)
  40. 1iah: Crystal Structure of The Atypical Protein Kinase Domain of a Trp Ca-channel, Chak (adp-mg Complex)
  41. 1iaj: Crystal Structure of The Atypical Protein Kinase Domain of a Trp Ca-channel, Chak (apo)
  42. 1ias: Cytoplasmic Domain of Unphosphorylated Type I Tgf-beta Receptor Crystallized without Fkbp12
  43. 1id0: Crystal Structure of The Nucleotide Bond Conformation of Phoq Kinase Domain
  44. 1ik7: Crystal Structure of The Uncomplexed Pelle Death Domain
  45. 1j1b: Binary Complex Structure of Human Tau Protein Kinase I with Amppnp
  46. 1j1c: Binary Complex Structure of Human Tau Protein Kinase I with Adp
  47. 1j3h: Crystal Structure of Apoenzyme Camp-dependent Protein Kinase Catalytic Subunit
  48. 1j91: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 4,5,6,7- Tetrabromobenzotriazole
  49. 1jam: Crystal Structure of Apo-form of Z. Mays Ck2 Protein Kinase Alpha Subunit
  50. 1jbp: Crystal Structure of The Catalytic Subunit of Camp- Dependent Protein Kinase Complexed with a Substrate Peptide, Adp and Detergent
  51. 1jlu: Crystal Structure of The Catalytic Subunit of Camp- Dependent Protein Kinase Complexed with a Phosphorylated Substrate Peptide and Detergent
  52. 1jvp: Crystal Structure of Human Cdk2 (unphosphorylated) in Complex with Pkf049-365
  53. 1jwh: Crystal Structure of Human Protein Kinase Ck2 Holoenzyme
  54. 1ke5: Cdk2 Complexed with N-methyl-4-{[(2-oxo-1,2-dihydro-3h- Indol-3-ylidene)methyl]amino}benzenesulfonamide
  55. 1ke6: Cyclin-dependent Kinase 2 (cdk2) Complexed with N-methyl-{4- [2-(7-oxo-6,7-dihydro-8h-[1,3]thiazolo[5,4-e]indol-8- Ylidene)hydrazino]phenyl}methanesulfonamide
  56. 1ke7: Cyclin-dependent Kinase 2 (cdk2) Complexed with 3-{[(2,2- Dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5- (1,3-oxazol-5-yl)-1,3-dihydro-2h-indol-2-one
  57. 1ke8: Cyclin-dependent Kinase 2 (cdk2) Complexed with 4-{[(2-oxo- 1,2-dihydro-3h-indol-3-ylidene)methyl]amino}-n-(1,3- Thiazol-2-yl)benzenesulfonamide
  58. 1ke9: Cyclin-dependent Kinase 2 (cdk2) Complexed with 3-{[4- ({[amino(imino)methyl]aminosulfonyl)anilino]methylene}-2- Oxo-2,3-dihydro-1h-indole
  59. 1ktz: Crystal Structure of The Human Tgf-beta Type II Receptor Extracellular Domain in Complex with Tgf-beta3
  60. 1l3r: Crystal Structure of a Transition State Mimic of The Catalytic Subunit of Camp-dependent Protein Kinase
  61. 1l6e: Solution Structure of The Docking and Dimerization Domain of Protein Kinase a Ii-alpha (riialpha D/d). Alternatively Called The N-terminal Dimerization Domain of The Regulatory Subunit of Protein Kinase A.
  62. 1ll8: Structure and Interactions of Pas Kinase N-terminal Pas Domain: Model for Intramolecular Kinase Regulation
  63. 1lp4: Crystal Structure of a Binary Complex of The Catalytic Subunit of Protein Kinase Ck2 with Mg-amppnp
  64. 1lpu: Low Temperature Crystal Structure of The Apo-form of The Catalytic Subunit of Protein Kinase Ck2 from Zea Mays
  65. 1lr4: Room Temperature Crystal Structure of The Apo-form of The Catalytic Subunit of Protein Kinase Ck2 from Zea Mays
  66. 1m2p: Crystal Structure of 1,8-di-hydroxy-4-nitro- Anthraquinone/ck2 Kinase Complex
  67. 1m2q: Crystal Structure of 1,8-di-hydroxy-4-nitro-xanten-9- One/ck2 Kinase Complex
  68. 1m2r: Crystal Structure of 5,8-di-amino-1,4-di-hydroxy- Anthraquinone/ck2 Kinase Complex
  69. 1mby: Murine Sak Polo Domain
  70. 1na7: Crystal Structure of The Catalytic Subunit of Human Protein Kinase Ck2
  71. 1o6k: Structure of Activated Form of Pkb Kinase Domain S474D with Gsk3 Peptide and Amp-pnp
  72. 1o6l: Crystal Structure of an Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex with Amp-pnp and Gsk3 Peptide
  73. 1o9u: Glycogen Synthase Kinase 3 Beta Complexed with Axin Peptide
  74. 1ogu: Structure of Human Thr160-phospho Cdk2/cyclin a Complexed with a 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine Inhibitor
  75. 1oi9: Structure of Human Thr160-phospho Cdk2/cyclin a Complexed with a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor
  76. 1oiq: Imidazopyridines: a Potent and Selective Class of Cyclin-dependent Kinase Inhibitors Identified through Structure-based Hybridisation
  77. 1oir: Imidazopyridines: a Potent and Selective Class of Cyclin-dependent Kinase Inhibitors Identified through Structure-based Hybridisation
  78. 1oit: Imidazopyridines: a Potent and Selective Class of Cyclin-dependent Kinase Inhibitors Identified through Structure-based Hybridisation
  79. 1oiu: Structure of Human Thr160-phospho Cdk2/cyclin a Complexed with a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor
  80. 1oiy: Structure of Human Thr160-phospho Cdk2/cyclin a Complexed with a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor
  81. 1okv: Cyclin a Binding Groove Inhibitor H-arg-arg-leu-ile-phe-nh2
  82. 1okw: Cyclin a Binding Groove Inhibitor Ac-arg-arg-leu-asn- (m-cl-phe)-nh2
  83. 1oky: Structure of Human Pdk1 Kinase Domain in Complex with Staurosporine
  84. 1okz: Structure of Human Pdk1 Kinase Domain in Complex with Ucn-01
  85. 1ol1: Cyclin a Binding Groove Inhibitor H-cit-cit-leu-ile- (p-f-phe)-nh2
  86. 1ol2: Cyclin a Binding Groove Inhibitor H-arg-arg-leu-asn- (p-f-phe)-nh2
  87. 1ol5: Structure of Aurora-a 122-403, Phosphorylated on Thr287, Thr288 and Bound to Tpx2 1-43
  88. 1ol6: Structure of Unphosphorylated D274N Mutant of Aurora-a
  89. 1ol7: Structure of Human Aurora-a 122-403 Phosphorylated on Thr287, Thr288
  90. 1om1: Crystal Structure of Maize Ck2 Alpha in Complex with Iqa
  91. 1ouk: The Structure of P38 Alpha in Complex with a Pyridinylimidazole Inhibitor
  92. 1ouy: The Structure of P38 Alpha in Complex with a Dihydropyrido- Pyrimidine Inhibitor
  93. 1ove: The Structure of P38 Alpha in Complex with a Dihydroquinolinone
  94. 1oz1: P38 Mitogen-activated Kinase in Complex with 4-azaindole Inhibitor
  95. 1pf8: Crystal Structure of Human Cyclin-dependent Kinase 2 Complexed with a Nucleoside Inhibitor
  96. 1pjk: Crystal Structure of a C-terminal Deletion Mutant of Human Protein Kinase Ck2 Catalytic Subunit
  97. 1plo: Transforming Growth Factor-beta Type II Receptor Extracellular Domain
  98. 1py5: Crystal Structure of Tgf-beta Receptor I Kinase with Inhibitor
  99. 1pyx: Gsk-3 Beta Complexed with Amp-pnp
  100. 1q24: Pka Double Mutant Model of Pkb in Complex with Mgatp
  101. 1q3d: Gsk-3 Beta Complexed with Staurosporine
  102. 1q3w: Gsk-3 Beta Complexed with Alsterpaullone
  103. 1q41: Gsk-3 Beta Complexed with Indirubin-3'-monoxime
  104. 1q4l: Gsk-3 Beta Complexed with Inhibitor I-5
  105. 1q5k: Crystal Structure of Glycogen Synthase Kinase 3 in Complexed with Inhibitor
  106. 1q61: Pka Triple Mutant Model of Pkb
  107. 1q62: Pka Double Mutant Model of Pkb
  108. 1q8t: The Catalytic Subunit of Camp-dependent Protein Kinase (pka) in Complex with Rho-kinase Inhibitor Y-27632
  109. 1q8u: The Catalytic Subunit of Camp-dependent Protein Kinase in Complex with Rho-kinase Inhibitor H-1152p
  110. 1q8w: The Catalytic Subunit of Camp-dependent Protein Kinase in Complex with Rho-kinase Inhibitor Fasudil (ha-1077)
  111. 1qf8: Truncated Form of Casein Kinase II Beta Subunit (2-182) from Homo Sapiens
  112. 1r0e: Glycogen Synthase Kinase-3 Beta in Complex with 3-indolyl-4- Arylmaleimide Inhibitor
  113. 1r2a: The Molecular Basis for Protein Kinase a Anchoring Revealed by Solution Nmr
  114. 1r39: The Structure of P38ALPHA
  115. 1r3c: The Structure of P38ALPHA C162S Mutant
  116. 1rdq: Hydrolysis of Atp in The Crystal of Y204A Mutant of Camp- Dependent Protein Kinase
  117. 1re8: Crystal Structure of Camp-dependent Protein Kinase Complexed with Balanol Analog 2
  118. 1rej: Crystal Structure of Camp-dependent Protein Kinase Complexed with Balanol Analog 1
  119. 1rek: Crystal Structure of Camp-dependent Protein Kinase Complexed with Balanol Analog 8
  120. 1rew: Structural Refinement of The Complex of Bone Morphogenetic Protein 2 and Its Type Ia Receptor
  121. 1rgs: Regulatory Subunit of Camp Dependent Protein Kinase
  122. 1rqf: Structure of Ck2 Beta Subunit Crystallized in The Presence of a P21WAF1 Peptide
  123. 1rw8: Crystal Structure of Tgf-beta Receptor I Kinase with Atp Site Inhibitor
  124. 1rwi: Extracellular Domain of Mycobacterium Tuberculosis Pknd
  125. 1rwl: Extracellular Domain of Mycobacterium Tuberculosis Pknd
  126. 1s4y: Crystal Structure of The Activin/actriib Extracellular Domain
  127. 1s9i: X-ray Structure of The Human Mitogen-activated Protein Kinase Kinase 2 (mek2)in a Complex with Ligand and Mgatp
  128. 1s9j: X-ray Structure of The Human Mitogen-activated Protein Kinase Kinase 1 (mek1) in a Complex with Ligand and Mgatp
  129. 1smh: Protein Kinase a Variant Complex with Completely Ordered N- Terminal Helix
  130. 1stc: Camp-dependent Protein Kinase, Alpha-catalytic Subunit in Complex with Staurosporine
  131. 1sve: Crystal Structure of Protein Kinase a in Complex with Azepane Derivative 1
  132. 1svg: Crystal Structure of Protein Kinase a in Complex with Azepane Derivative 4
  133. 1svh: Crystal Structure of Protein Kinase a in Complex with Azepane Derivative 8
  134. 1syk: Crystal Structure of E230Q Mutant of Camp-dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation
  135. 1szm: Dual Binding Mode of Bisindolylmaleimide 2 to Protein Kinase a (pka)
  136. 1th8: Crystal Structures of The Adp and Atp Bound Forms of The Bacillus Anti-sigma Factor Spoiiab in Complex with The Anti-anti-sigma Spoiiaa: Inhibitory Complex with Adp, Crystal Form II
  137. 1thn: Crystal Structures of The Adp and Atp Bound Forms of The Bacillus Anti-sigma Factor Spoiiab in Complex with The Anti-anti-sigma Spoiiaa: Inhibitory Complex with Adp, Crystal Form I
  138. 1tid: Crystal Structures of The Adp and Atp Bound Forms of The Bacillus Anti-sigma Factor Spoiiab in Complex with The Anti-anti-sigma Spoiiaa: Poised for Phosphorylation Complex with Atp, Crystal Form I
  139. 1til: Crystal Structures of The Adp and Atp Bound Forms of The Bacillus Anti-sigma Factor Spoiiab in Complex with The Anti-anti-sigma Spoiiaa:poised for Phosphorylation Complex with Atp, Crystal Form II
  140. 3e3p: Glycogen Synthase Kinase from Leishmania Major
  141. 1tvo: The Structure of Erk2 in Complex with a Small Molecule Inhibitor
  142. 1ua2: Crystal Structure of Human Cdk7
  143. 1ukh: Structural Basis for The Selective Inhibition of Jnk1 by The Scaffolding Protein Jip1 and Sp600125
  144. 1uki: Structural Basis for The Selective Inhibition of Jnk1 by The Scaffolding Protein Jip1 and Sp600125
  145. 1urc: Cyclin a Binding Groove Inhibitor Ace-arg-lys-leu- Phe-gly
  146. 1urw: Cdk2 in Complex with an Imidazo[1,2-b]pyridazine
  147. 1uti: Mona/gads SH3C in Complex with Hpk Derived Peptide
  148. 1uu3: Structure of Human Pdk1 Kinase Domain in Complex with Ly333531
  149. 1uu7: Structure of Human Pdk1 Kinase Domain in Complex with Bim-2
  150. 1uu8: Structure of Human Pdk1 Kinase Domain in Complex with Bim-1
  151. 1uu9: Structure of Human Pdk1 Kinase Domain in Complex with Bim-3
  152. 1uv5: Glycogen Synthase Kinase 3 Beta Complexed with 6-bromoindirubin-3'-oxime
  153. 1uvr: Structure of Human Pdk1 Kinase Domain in Complex with Bim-8
  154. 1uwh: The Complex of Wild Type B-raf and Bay439006
  155. 1uwj: The Complex of Mutant V599E B-raf and Bay439006
  156. 1v1k: Cdk2 in Complex with a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor
  157. 1vd2: Solution Structure of The Pb1 Domain of Pkciota
  158. 1veb: Crystal Structure of Protein Kinase a in Complex with Azepane Derivative 5
  159. 1vjy: Crystal Structure of a Naphthyridine Inhibitor of Human Tgf- Beta Type I Receptor
  160. 1vyw: Structure of Cdk2/cyclin a with Pnu-292137
  161. 1vyz: Structure of Cdk2 Complexed with Pnu-181227
  162. 1vzo: The Structure of The N-terminal Kinase Domain of Msk1 Reveals a Novel Autoinhibitory Conformation for a Dual Kinase Protein
  163. 1w0x: Crystals Structure of Human Cdk2 in Complex with The Inhibitor Olomoucine.
  164. 1w1d: Crystal Structure of The Pdk1 Pleckstrin Homology (ph) Domain Bound to Inositol (1,3,4,5)-tetrakisphosphate
  165. 1w1g: Crystal Structure of The Pdk1 Pleckstrin Homology (ph) Domain Bound to Dic4-phosphatidylinositol (3,4,5)- Trisphosphate
  166. 1w1h: Crystal Structure of The Pdk1 Pleckstrin Homology (ph) Domain
  167. 1w7h: P38 Kinase Crystal Structure in Complex with Small Molecule Inhibitor
  168. 1w82: P38 Kinase Crystal Structure in Complex with Small Molecule Inhibitor
  169. 1w83: P38 Kinase Crystal Structure in Complex with Small Molecule Inhibitor
  170. 1w84: P38 Kinase Crystal Structure in Complex with Small Molecule Inhibitor
  171. 1w8c: Co-crystal Structure of 6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine and Monomeric Cdk2
  172. 1w98: The Structural Basis of Cdk2 Activation by Cyclin E
  173. 1wak: X-ray Structure of Srpk1
  174. 1wbn: Fragment Based P38 Inhibitors
  175. 1wbo: Fragment Based P38 Inhibitors
  176. 1wbp: Srpk1 Bound to 9mer Docking Motif Peptide
  177. 1wbs: Identification of Novel P38 Alpha Map Kinase Inhibitors Using Fragment-based Lead Generation.
  178. 1wbt: Identification of Novel P38 Alpha Map Kinase Inhibitors Using Fragment-based Lead Generation.
  179. 1wbv: Identification of Novel P38 Alpha Map Kinase Inhibitors Using Fragment-based Lead Generation.
  180. 1wbw: Identification of Novel P38 Alpha Map Kinase Inhibitors Using Fragment-based Lead Generation.
  181. 1wcc: Screening for Fragment Binding by X-ray Crystallography
  182. 1wh4: Solution Structure of The Death Domain of Interleukin-1 Receptor-associated Kinase4 (irak4) from Mus Musculus
  183. 1wmh: Crystal Structure of a Pb1 Domain Complex of Protein Kinase C Iota and Par6 Alpha
  184. 1wmk: Human Death-associated Kinase Drp-1, Mutant S308D D40
  185. 1wrz: Calmodulin Complexed with a Peptide from a Human Death- Associated Protein Kinase
  186. 1wvw: Crystal Structures of Kinase Domain of Dap Kinase in Complex with Small Molecular Inhibitors
  187. 1wvx: Crystal Structures of Kinase Domain of Dap Kinase in Complex with Small Molecular Inhibitors
  188. 1wvy: Crystal Structures of Kinase Domain of Dap Kinase in Complex with Small Molecular Inhibitors
  189. 1wxm: Solution Structure of The N-terminal Ras-binding Domain (rbd) in Human A-raf Kinase
  190. 1wzy: Crystal Structure of Human Erk2 Complexed with a Pyrazolopyridazine Derivative
  191. 1x9x: Solution Structure of Dimeric Sam Domain from Mapkkk Ste11
  192. 1xh4: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  193. 1xh5: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  194. 1xh6: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  195. 1xh7: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  196. 1xh8: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  197. 1xh9: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  198. 1xha: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
  199. 2xmy: Discovery and Characterisation of 2-anilino-4-(thiazol-5-yl) Pyrimidine Transcriptional Cdk Inhibitors as Anticancer Agents
  200. 1xo2: Crystal Structure of a Human Cyclin-dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin
  201. 1xqz: Crystal Structure of Hpim-1 Kinase at 2.1 a Resolution
  202. 1xr1: Crystal Structure of Hpim-1 Kinase in Complex with Amp-pnp at 2.1 a Resolution
  203. 1xte: Crystal Structure of Cisk-px Domain
  204. 1xtn: Crystal Structure of Cisk-px Domain with Sulfates
  205. 1xws: Crystal Structure of The Human Pim1 Kinase Domain
  206. 2x1n: Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a through Structure Guided Design
  207. 1y8g: Catalytic and Ubiqutin-associated Domains of Mark2/par-1: Inactive Double Mutant with Selenomethionine
  208. 2wxv: Structure of Cdk2-cyclin a with a Pyrazolo(4,3-h) Quinazoline-3-carboxamide Inhibitor
  209. 1y8y: Crystal Structure of Human Cdk2 Complexed with a Pyrazolo[1, 5-a]pyrimidine Inhibitor
  210. 1y91: Crystal Structure of Human Cdk2 Complexed with a Pyrazolo[1, 5-a]pyrimidine Inhibitor
  211. 1ydr: Structure of Camp-dependent Protein Kinase, Alpha-catalytic Subunit in Complex with H7 Protein Kinase Inhibitor 1-(5- Isoquinolinesulfonyl)-2-methylpiperazine
  212. 1yds: Structure of Camp-dependent Protein Kinase, Alpha-catalytic Subunit in Complex with H8 Protein Kinase Inhibitor [n-(2- Methylamino)ethyl]-5-isoquinolinesulfonamide
  213. 1ydt: Structure of Camp-dependent Protein Kinase, Alpha-catalytic Subunit in Complex with H89 Protein Kinase Inhibitor N-[2- (4-bromocinnamylamino)ethyl]-5-isoquinoline
  214. 1ygo: Solution Structure of The Pelle Death Domain
  215. 1yhs: Crystal Structure of Pim-1 Bound to Staurosporine
  216. 1yhv: Crystal Structure of Pak1 Kinase Domain with Two Point Mutations (K299R, T423E)
  217. 1yhw: Crystal Structure of Pak1 Kinase Domain with One Point Mutations (K299R)
  218. 1yi3: Crystal Structure of Pim-1 Bound to Ly294002
  219. 1yi4: Structure of Pim-1 Bound to Adenosine
  220. 2wpa: Optimisation of 6,6-dimethyl Pyrrolo 3,4-c Pyrazoles: Identification of Pha-793887, a Potent Cdk Inhibitor Suitable for Intravenous Dosing
  221. 1ykr: Crystal Structure of Cdk2 with an Aminoimidazo Pyridine Inhibitor
  222. 1yqj: Crystal Structure of P38 Alpha in Complex with a Selective Pyridazine Inhibitor
  223. 1yr5: 1.7-a Structure of Calmodulin Bound to a Peptide from Dap Kinase
  224. 1yrp: Catalytic Domain of Human Zip Kinase Phosphorylated at Thr265
  225. 2wip: Structure of Cdk2-cyclin a Complexed with 8-anilino-1- Methyl-4,5-dihydro-1h-pyrazolo[4,3-h] Quinazoline-3- Carboxylic Acid
  226. 2wih: Structure of Cdk2-cyclin a with Pha-848125
  227. 2whb: Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a through Structure Guided Design
  228. 1yw2: Mutated Mus Musculus P38 Kinase (mp38)
  229. 1ywr: Crystal Structure Analysis of Inactive P38 Kinase Domain in Complex with a Monocyclic Pyrazolone Inhibitor
  230. 1ywv: Crystal Structures of Proto-oncogene Kinase Pim1: a Target of Aberrant Somatic Hypermutations in Diffuse Large Cell Lymphoma
  231. 2wfy: Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a through Structure Guided Design
  232. 2wev: Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a through Structure Guided Design
  233. 1yxs: Crystal Structure of Kinase Pim1 with P123M Mutation
  234. 1yxt: Crystal Structure of Kinase Pim1 in Complex with Amppnp
  235. 1yxu: Crystal Structure of Kinase Pim1 in Complex with Amp
  236. 1yxv: Crystal Structure of Kinase Pim1 in Complex with 3,4- Dihydroxy-1-methylquinolin-2(1h)-one
  237. 1yxx: Crystal Structure of Kinase Pim1 in Complex with (3e)-3-[(4- Hydroxyphenyl)imino]-1h-indol-2(3h)-one
  238. 1z5m: Crystal Structure of N1-[3-[[5-bromo-2-[[3-[(1- Pyrrolidinylcarbonyl)amino]phenyl]amino]-4- Pyrimidinyl]amino]propyl]-2,2-dimethylpropanediamide Complexed with Human Pdk1
  239. 1z9x: Human Drp-1 Kinase, W305S S308A D40 Mutant, Crystal Form with 3 Monomers in The Asymmetric Unit
  240. 2w1h: Fragment-based Discovery of The Pyrazol-4-yl Urea (at9283), a Multi-targeted Kinase Inhibitor with Potent Aurora Kinase Activity
  241. 1zlt: Crystal Structure of Chk1 Complexed with a Hymenaldisine Analog
  242. 1zmu: Catalytic and Ubiqutin-associated Domains of Mark2/par-1: Wild Type
  243. 1zmv: Catalytic and Ubiqutin-associated Domains of Mark2/par-1: K82R Mutant
  244. 1zmw: Catalytic and Ubiqutin-associated Domains of Mark2/par-1: T208A/S212A Inactive Double Mutant
  245. 1zoe: Crystal Structure of Protein Kinase Ck2 in Complex with Tbb- Derivatives Inhibitors
  246. 1zog: Crystal Structure of Protein Kinase Ck2 in Complex with Tbb- Derivatives
  247. 1zoh: Crystal Structure of Protein Kinase Ck2 in Complex with Tbb- Derivatives Inhibitors
  248. 1zsg: Beta Pix-sh3 Complexed with an Atypical Peptide from Alpha- Pak
  249. 1zxa: Solution Structure of The Coiled-coil Domain of Cgmp- Dependent Protein Kinase Ia
  250. 1zxe: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: D835N Inactivating Mutant in Apo Form
  251. 1zy4: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: R794G Hyperactivating Mutant in Apo Form.
  252. 1zy5: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: R794G Hyperactivating Mutant Complexed with Amppnp.
  253. 1zyc: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: Wild- Type in Apo Form.
  254. 1zyd: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: Wild- Type Complexed with Atp.
  255. 1zyj: Human P38 Map Kinase in Complex with Inhibitor 1a
  256. 1zys: Co-crystal Structure of Checkpoint Kinase Chk1 with a Pyrrolo-pyridine Inhibitor
  257. 1zz2: Two Classes of P38ALPHA Map Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes
  258. 1zzl: Crystal Structure of P38 with Triazolopyridine
  259. 2a0c: Human Cdk2 in Complex with Olomoucine Ii, a Novel 2,6,9- Trisubstituted Purine Cyclin-dependent Kinase Inhibitor
  260. 2a0t: Nmr Structure of The Fha1 Domain of Rad53 in Complex with a Biological Relevant Phosphopeptide Derived from Madt1
  261. 2a27: Human Drp-1 Kinase, W305S S308A D40 Mutant, Crystal Form with 8 Monomers in The Asymmetric Unit
  262. 2a2a: High-resolution Crystallographic Analysis of The Autoinhibited Conformation of a Human Death-associated Protein Kinase
  263. 2a4l: Human Cyclin-dependent Kinase 2 in Complex with Roscovitine
  264. 2a9i: Molecular Structure of The Interleukin-1 Receptor- Associated Kinase-4 Death Domain
  265. 2ac3: Structure of Human Mnk2 Kinase Domain
  266. 2ac5: Structure of Human Mnk2 Kinase Domain Mutant D228G
  267. 2v22: Replace: a Strategy for Iterative Design of Cyclin Binding Groove Inhibitors
  268. 2v0d: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  269. 2uzo: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  270. 2uzn: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  271. 2uzl: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  272. 2uze: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  273. 2uzd: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  274. 2uzb: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  275. 2ayp: Crystal Structure of Chk1 with an Indol Inhibitor
  276. 2b1p: Inhibitor Complex of Jnk3
  277. 2b52: Human Cyclin Dependent Kinase 2 (cdk2) Complexed with Dph- 042562
  278. 2b53: Human Cyclin Dependent Kinase 2 (cdk2) Complexed with Din- 234325
  279. 2b54: Human Cyclin Dependent Kinase 2 (ckd2)complexed with Din- 232305
  280. 2b55: Human Cyclin Dependent Kinase 2 (cdk2) Complexed with Indenopyraxole Din-101312
  281. 2b9f: Crystal Structure of Non-phosphorylated Fus3
  282. 2b9h: Crystal Structure of Fus3 with a Docking Motif from Ste7
  283. 2b9i: Crystal Structure of Fus3 with a Docking Motif from Msg5
  284. 2b9j: Crystal Structure of Fus3 with a Docking Motif from Far1
  285. 2baj: P38ALPHA Bound to Pyrazolourea
  286. 2bak: P38ALPHA Map Kinase Bound to Mpaq
  287. 2bal: P38ALPHA Map Kinase Bound to Pyrazoloamine
  288. 2baq: P38ALPHA Bound to Ro3201195
  289. 2bhe: Human Cyclin Dependent Protein Kinase 2 in Complex with The Inhibitor 5-bromo-indirubine
  290. 2bhh: Human Cyclin Dependent Protein Kinase 2 in Complex with The Inhibitor 4-hydroxypiperindinesulfonyl-indirubine
  291. 2bik: Human Pim1 Phosphorylated on Ser261
  292. 2bil: The Human Protein Kinase Pim1 in Complex with Its Consensus Peptide Pimtide
  293. 2biy: Structure of PDK1-S241A Mutant Kinase Domain
  294. 2bkz: Structure of Cdk2-cyclin a with Pha-404611
  295. 2bmc: Aurora-2 T287D T288D Complexed with Pha-680632
  296. 2bpm: Structure of Cdk2-cyclin a with Pha-630529
  297. 2br1: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  298. 2brb: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  299. 2brg: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  300. 2brh: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  301. 2brm: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  302. 2brn: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  303. 2bro: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
  304. 2btr: Structure of Cdk2 Complexed with Pnu-198873
  305. 2bts: Structure of Cdk2 Complexed with Pnu-230032
  306. 2buj: Crystal Structure of The Human Serine-threonine Kinase 16 in Complex with Staurosporine
  307. 2bva: Crystal Structure of The Human P21-activated Kinase 4
  308. 2bzh: Crystal Structure of The Human Pim1 in Complex with a Ruthenium Organometallic Ligand Ru1
  309. 2bzi: Crystal Structure of The Human Pim1 in Complex with a Ruthenium Organometallic Ligand Ru2
  310. 2bzj: Crystal Structure of The Human Pim1 in Complex with a Ruthenium Organometallic Ligand Ru3
  311. 2bzk: Crystal Structure of The Human Pim1 in Complex with Amppnp and Pimtide
  312. 2c1a: Structure of Camp-dependent Protein Kinase Complexed with Isoquinoline-5-sulfonic Acid (2-(2-(4-chlorobenzyloxy) Ethylamino)ethyl)amide
  313. 2c1b: Structure of Camp-dependent Protein Kinase Complexed with ( 4r,2s)-5'-(4-(4-chlorobenzyloxy)pyrrolidin-2- Ylmethanesulfonyl)isoquinoline
  314. 2c30: Crystal Structure of The Human P21-activated Kinase 6
  315. 2c3i: Crystal Structure of Human Pim1 in Complex with Imidazopyridazin I
  316. 2c3j: Identification of a Buried Pocket for Potent and Selective Inhibition of Chk1: Prediction and Verification
  317. 2c3k: Identification of a Buried Pocket for Potent and Selective Inhibition of Chk1: Prediction and Verification
  318. 2c3l: Identification of a Buried Pocket for Potent and Selective Inhibition of Chk1: Prediction and Verification
  319. 2c4g: Structure of Cdk2-cyclin a with Pha-533514
  320. 2c5n: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
  321. 2c5o: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
  322. 2c5v: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
  323. 2c5x: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
  324. 2c5y: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
  325. 2c60: Crystal Structure of Human Mitogen-activated Protein Kinase Kinase Kinase 3 Isoform 2 Phox Domain at 1.25 a Resolution
  326. 2c68: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  327. 2c69: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  328. 2c6d: Aurora a Kinase Activated Mutant (T287D) in Complex with Adpnp
  329. 2c6e: Aurora a Kinase Activated Mutant (T287D) in Complex with a 5-aminopyrimidinyl Quinazoline Inhibitor
  330. 2c6i: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  331. 2c6k: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  332. 2c6l: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  333. 2c6m: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  334. 2c6o: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  335. 2c6t: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
  336. 2cdz: Crystal Structure of The Human P21-activated Kinase 4 in Complex with CGP74514A
  337. 2cgu: Identification of Chemically Diverse Chk1 Inhibitors by Receptor-based Virtual Screening
  338. 2cgv: Identification of Chemically Diverse Chk1 Inhibitors by Receptor-based Virtual Screening
  339. 2cgw: Identification of Chemically Diverse Chk1 Inhibitors by Receptor-based Virtual Screening
  340. 2cgx: Identification of Chemically Diverse Chk1 Inhibitors by Receptor-based Virtual Screening
  341. 2cjm: Mechanism of Cdk Inhibition by Active Site Phosphorylation: Cdk2 Y15P T160P in Complex with Cyclin a Structure
  342. 2clx: 4-arylazo-3,5-diamino-1h-pyrazole Cdk Inhibitors: Sar Study, Crystal Structure in Complex with Cdk2, Selectivity, and Cellular Effects
  343. 2cos: Solution Structure of Rsgi Ruh-038, a Uba Domain from Mouse Lats2 (large Tumor Suppressor Homolog 2)
  344. 2cpk: Crystal Structure of The Catalytic Subunit of Cyclic Adenosine Monophosphate-dependent Protein Kinase
  345. 2cu1: Solution Structure of The Pb1 Domain of Human Protein Kinase MEKK2B
  346. 2df6: Crystal Structure of The Sh3 Domain of Betapix in Complex with a High Affinity Peptide from Pak2
  347. 2drn: Docking and Dimerization Domain (d/d) of The Type Ii-alpha Regulatory Subunity of Protein Kinase a (pka) in Complex with a Peptide from an A-kinase Anchoring Protein
  348. 2erz: Crystal Structure of C-amp Dependent Kinase (pka) Bound to Hydroxyfasudil
  349. 2esm: Crystal Structure of Rock 1 Bound to Fasudil
  350. 2etk: Crystal Structure of Rock 1 Bound to Hydroxyfasudil
  351. 2etr: Crystal Structure of Rock I Bound to Y-27632
  352. 2euf: X-ray Structure of Human Cdk6-vcyclin in Complex with The Inhibitor Pd0332991
  353. 2eva: Structural Basis for The Interaction of Tak1 Kinase with Its Activating Protein Tab1
  354. 2ewa: Dual Binding Mode of Pyridinylimidazole to Map Kinase P38
  355. 2exc: Inhibitor Complex of Jnk3
  356. 2exm: Human Cdk2 in Complex with Isopentenyladenine
  357. 2ezw: Solution Structure of The Docking and Dimerization Domain of The Type I Alpha Regulatory Subunit of Protein Kinase a (rialpha D/d)
  358. 2f2c: X-ray Structure of Human Cdk6-vcyclinwith The Inhibitor Aminopurvalanol
  359. 2f2u: Crystal Structure of The Rho-kinase Kinase Domain
  360. 2f49: Crystal Structure of Fus3 in Complex with a Ste5 Peptide
  361. 2f57: Crystal Structure of The Human P21-activated Kinase 5
  362. 2f7e: Pka Complexed with (s)-2-(1h-indol-3-yl)-1-(5-isoquinolin-6- Yl-pyridin-3-yloxymethyl-etylamine
  363. 2f7x: Protein Kinase a Bound to (s)-2-(1h-indol-3-yl)-1-[5-((e)-2- Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
  364. 2f7z: Protein Kinase a Bound to (r)-1-(1h-indol-3-ylmethyl)-2-(2- Pyridin-4-yl-[1,7]naphtyridin-5-yloxy)-ehylamine
  365. 2f9g: Crystal Structure of Fus3 Phosphorylated on Tyr182
  366. 2fa2: Crystal Structure of Fus3 without a Peptide from Ste5
  367. 2fb8: Structure of The B-raf Kinase Domain Bound to Sb-590885
  368. 2fk9: Human Protein Kinase C, Eta
  369. 2fsl: Mitogen Activated Protein Kinase P38ALPHA (D176A+F327S) Activating Mutant Form-a
  370. 2fsm: Mitogen Activated Protein Kinase P38ALPHA (D176A+F327S) Activating Mutant Form-b
  371. 2fso: Mitogen Activated Protein Kinase P38ALPHA (D176A) Activating Mutant
  372. 2fst: Mitogen Activated Protein Kinase P38ALPHA (D176A+F327L) Activating Mutant
  373. 2fum: Catalytic Domain of Protein Kinase Pknb from Mycobacterium Tuberculosis in Complex with Mitoxantrone
  374. 2fvd: Cyclin Dependent Kinase 2 (cdk2) with Diaminopyrimidine Inhibitor
  375. 2fys: Crystal Structure of Erk2 Complex with Kim Peptide Derived from Mkp3
  376. 2g01: Pyrazoloquinolones as Novel, Selective Jnk1 Inhibitors
  377. 2g9x: Structure of Thr 160 Phosphorylated Cdk2/cyclin a in Complex with The Inhibitor Nu6271
  378. 2gbl: Crystal Structure of Full Length Circadian Clock Protein Kaic with Phosphorylation Sites
  379. 2gcd: Tao2 Kinase Domain-staurosporine Structure
  380. 2gdo: 4-(aminoalkylamino)-3-benzimidazole-quinolinones as Potent Chk1 Inhibitors
  381. 2gfc: Camp-dependent Protein Kinase Pka Catalytic Subunit with Pki-5-24
  382. 2gfs: P38 Kinase Crystal Structure in Complex with Ro3201195
  383. 2ghg: H-chk1 Complexed with A431994
  384. 2ghl: Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor Pg-874743
  385. 2ghm: Mutated Map Kinase P38 (mus Musculus) in Complex with Inhbitor Pg-895449
  386. 2gu8: Discovery of 2-pyrimidyl-5-amidothiophenes as Novel and Potent Inhibitors for Akt: Synthesis and Sar Studies
  387. 2h9r: Docking and Dimerization Domain (d/d) of The Regulatory Subunit of The Type Ii-alpha Camp-dependent Protein Kinase a Associated with a Peptide Derived from an A-kinase Anchoring Protein (akap)
  388. 2iw6: Structure of Human Thr160-phospho Cdk2-cyclin a Complexed with a Bisanilinopyrimidine Inhibitor
  389. 2iw8: Structure of Human Thr160-phospho Cdk2-cyclin a F82H-L83V- H84D Mutant with an O6-cyclohexylmethylguanine Inhibitor
  390. 2iw9: Structure of Human Thr160-phospho Cdk2-cyclin a Complexed with a Bisanilinopyrimidine Inhibitor
  391. 2j0i: Crystal Structure of The Human P21-activated Kinase 4
  392. 2j4z: Structure of Aurora-2 in Complex with Pha-680626
  393. 2j9m: Crystal Structure of Cdk2 in Complex with Macrocyclic Aminopyrimidine
  394. 3ndm: Crystal Structure of Rho-associated Protein Kinase (rock1) with a Potent Isoquinolone Derivative
  395. 2xix: Protein Kinase Pim-1 in Complex with Fragment-1 from Crystallographic Fragment Screen
  396. 2xiy: Protein Kinase Pim-1 in Complex with Fragment-2 from Crystallographic Fragment Screen
  397. 2xiz: Protein Kinase Pim-1 in Complex with Fragment-3 from Crystallographic Fragment Screen
  398. 2xj0: Protein Kinase Pim-1 in Complex with Fragment-4 from Crystallographic Fragment Screen
  399. 2xj1: Protein Kinase Pim-1 in Complex with Small Molecule Inibitor
  400. 3pna: Crystal Structure of Camp Bound (91-244)ria Subunit of Camp-dependent Protein Kinase
  401. 4a7c: Crystal Structure of Pim1 Kinase with Etp46546
  402. 4a9y: P38ALPHA Map Kinase Bound to Cmpd 8
  403. 4aa0: P38ALPHA Map Kinase Bound to Cmpd 2
  404. 4aa4: P38ALPHA Map Kinase Bound to Cmpd 22
  405. 4aa5: P38ALPHA Map Kinase Bound to Cmpd 33
  406. 4app: Crystal Structure of The Human P21-activated Kinase 4 in Complex with (s)-n-(5-(3-benzyl-1-methylpiperazine-4- Carbonyl)-6,6-dimethyl-1,4,5,6-tetrahydropyrrolo(3,4-c) Pyrazol-3-yl)-3-phenoxybenzamide
  407. 4alu: Benzofuropyrimidinone Inhibitors of Pim-1
  408. 4alv: Benzofuropyrimidinone Inhibitors of Pim-1
  409. 4alw: Benzofuropyrimidinone Inhibitors of Pim-1
  410. 4g1w: Crystal Structure of Jnk1 in Complex with Jip1 Peptide and 7-fluoro-3- [4-(2-hydroxy-ethanesulfonyl)-benzyl]-4-oxo-1-phenyl-1,4-dihydro- Quinoline-2-carboxylic Acid Methyl Ester
  411. 4hys: Crystal Structure of Jnk1 in Complex with Jip1 Peptide and 4-(4- Indazol-1-yl-pyrimidin-2-ylamino)-cyclohexan
  412. 4hyu: Crystal Structure of Jnk1 in Complex with Jip1 Peptide and 4-{4-[4-(3- Methanesulfonyl-propoxy)-indazol-1-yl]-pyrimidin-2-ylamino}- Cyclohexan
  413. 4izy: Crystal Structure of Jnk1 in Complex with Jip1 Peptide and 4-{4-[4-(4- Methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}- Cyclohexan
© Copyright 2008-2009 by enzymes.me.uk